HEADER IMMUNE SYSTEM 28-JAN-15 4XW2 TITLE STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT TITLE 2 RECEPTOR 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-M; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 145-337; COMPND 5 SYNONYM: CD11 ANTIGEN-LIKE FAMILY MEMBER B,CR-3 ALPHA CHAIN,CELL COMPND 6 SURFACE GLYCOPROTEIN MAC-1 SUBUNIT ALPHA,LEUKOCYTE ADHESION RECEPTOR COMPND 7 MO1,NEUTROPHIL ADHERENCE RECEPTOR; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: THE DISCREPANCIES COME FROM THE EXPRESSION VECTOR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITGAM, CD11B, CR3A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS IMMUNE SYSTEM, COMPLEMENT RECEPTOR 3, ROSSMANN FOLD, INTEGRIN, KEYWDS 2 STATIN, PROTEIN-INHIBITOR COMPLEX, MAC-1, I DOMAIN, VWA EXPDTA X-RAY DIFFRACTION AUTHOR G.BAJIC,M.R.JENSEN,T.VORUP-JENSEN,G.R.ANDERSEN REVDAT 6 10-JAN-24 4XW2 1 REMARK REVDAT 5 17-JAN-18 4XW2 1 REMARK REVDAT 4 24-AUG-16 4XW2 1 JRNL REVDAT 3 06-JUL-16 4XW2 1 JRNL REVDAT 2 20-JAN-16 4XW2 1 REVDAT 1 13-JAN-16 4XW2 0 JRNL AUTH M.R.JENSEN,G.BAJIC,X.ZHANG,A.K.LAUSTSEN,H.KOLDS,K.K.SKEBY, JRNL AUTH 2 B.SCHITT,G.R.ANDERSEN,T.VORUP-JENSEN JRNL TITL STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF JRNL TITL 2 COMPLEMENT RECEPTOR 3. JRNL REF J.BIOL.CHEM. V. 291 16963 2016 JRNL REFN ESSN 1083-351X JRNL PMID 27339893 JRNL DOI 10.1074/JBC.M116.732222 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13334 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.060 REMARK 3 FREE R VALUE TEST SET COUNT : 941 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2031 - 3.8256 1.00 1876 145 0.1759 0.2153 REMARK 3 2 3.8256 - 3.0375 1.00 1800 130 0.1797 0.2140 REMARK 3 3 3.0375 - 2.6538 1.00 1784 119 0.1908 0.2011 REMARK 3 4 2.6538 - 2.4113 1.00 1752 136 0.1996 0.2469 REMARK 3 5 2.4113 - 2.2385 1.00 1727 144 0.2086 0.2854 REMARK 3 6 2.2385 - 2.1066 1.00 1741 134 0.1961 0.2590 REMARK 3 7 2.1066 - 2.0011 0.99 1713 133 0.2043 0.2586 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.340 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1550 REMARK 3 ANGLE : 1.052 2088 REMARK 3 CHIRALITY : 0.052 233 REMARK 3 PLANARITY : 0.005 271 REMARK 3 DIHEDRAL : 12.912 639 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XW2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JAN-15. REMARK 100 THE DEPOSITION ID IS D_1000206399. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13336 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 29.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 9.000 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.58300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.140 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1IDO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM MALONATE PH 7.0, 20% REMARK 280 (W/V) PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.19000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 29.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.84500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 29.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.19000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.84500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 124 REMARK 465 ALA A 125 REMARK 465 MET A 126 REMARK 465 GLY A 127 REMARK 465 SER A 128 REMARK 465 PRO A 129 REMARK 465 GLN A 130 REMARK 465 GLU A 131 REMARK 465 GLY A 316 REMARK 465 PHE A 317 REMARK 465 ALA A 318 REMARK 465 ILE A 319 REMARK 465 GLU A 320 REMARK 465 GLY A 321 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 177 -105.53 -141.10 REMARK 500 LEU A 206 177.70 62.14 REMARK 500 PHE A 223 39.07 -89.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 555 DISTANCE = 6.52 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 401 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 142 OG REMARK 620 2 SER A 144 OG 97.0 REMARK 620 3 THR A 209 OG1 88.2 173.2 REMARK 620 4 SIM A 402 O1A 92.5 84.7 90.7 REMARK 620 5 HOH A 563 O 85.7 86.9 97.9 171.1 REMARK 620 6 HOH A 564 O 173.8 88.0 87.1 91.6 90.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SIM A 402 DBREF 4XW2 A 129 321 UNP P11215 ITAM_HUMAN 145 337 SEQADV 4XW2 GLY A 124 UNP P11215 EXPRESSION TAG SEQADV 4XW2 ALA A 125 UNP P11215 EXPRESSION TAG SEQADV 4XW2 MET A 126 UNP P11215 EXPRESSION TAG SEQADV 4XW2 GLY A 127 UNP P11215 EXPRESSION TAG SEQADV 4XW2 SER A 128 UNP P11215 EXPRESSION TAG SEQADV 4XW2 GLY A 316 UNP P11215 ILE 332 CONFLICT SEQRES 1 A 198 GLY ALA MET GLY SER PRO GLN GLU ASP SER ASP ILE ALA SEQRES 2 A 198 PHE LEU ILE ASP GLY SER GLY SER ILE ILE PRO HIS ASP SEQRES 3 A 198 PHE ARG ARG MET LYS GLU PHE VAL SER THR VAL MET GLU SEQRES 4 A 198 GLN LEU LYS LYS SER LYS THR LEU PHE SER LEU MET GLN SEQRES 5 A 198 TYR SER GLU GLU PHE ARG ILE HIS PHE THR PHE LYS GLU SEQRES 6 A 198 PHE GLN ASN ASN PRO ASN PRO ARG SER LEU VAL LYS PRO SEQRES 7 A 198 ILE THR GLN LEU LEU GLY ARG THR HIS THR ALA THR GLY SEQRES 8 A 198 ILE ARG LYS VAL VAL ARG GLU LEU PHE ASN ILE THR ASN SEQRES 9 A 198 GLY ALA ARG LYS ASN ALA PHE LYS ILE LEU VAL VAL ILE SEQRES 10 A 198 THR ASP GLY GLU LYS PHE GLY ASP PRO LEU GLY TYR GLU SEQRES 11 A 198 ASP VAL ILE PRO GLU ALA ASP ARG GLU GLY VAL ILE ARG SEQRES 12 A 198 TYR VAL ILE GLY VAL GLY ASP ALA PHE ARG SER GLU LYS SEQRES 13 A 198 SER ARG GLN GLU LEU ASN THR ILE ALA SER LYS PRO PRO SEQRES 14 A 198 ARG ASP HIS VAL PHE GLN VAL ASN ASN PHE GLU ALA LEU SEQRES 15 A 198 LYS THR ILE GLN ASN GLN LEU ARG GLU LYS GLY PHE ALA SEQRES 16 A 198 ILE GLU GLY HET MG A 401 1 HET SIM A 402 31 HETNAM MG MAGNESIUM ION HETNAM SIM SIMVASTATIN ACID HETSYN SIM DIMETHYL-COMPACTIN FORMUL 2 MG MG 2+ FORMUL 3 SIM C25 H40 O6 FORMUL 4 HOH *65(H2 O) HELIX 1 AA1 ILE A 146 LEU A 164 1 19 HELIX 2 AA2 THR A 185 ASN A 192 1 8 HELIX 3 AA3 ASN A 194 LYS A 200 1 7 HELIX 4 AA4 HIS A 210 LEU A 222 1 13 HELIX 5 AA5 ASN A 224 GLY A 228 5 5 HELIX 6 AA6 GLY A 251 ASP A 254 5 4 HELIX 7 AA7 VAL A 255 GLU A 262 1 8 HELIX 8 AA8 SER A 277 ALA A 288 1 12 HELIX 9 AA9 PRO A 291 ASP A 294 5 4 HELIX 10 AB1 PHE A 302 LYS A 315 1 14 SHEET 1 AA1 6 PHE A 180 PHE A 184 0 SHEET 2 AA1 6 THR A 169 TYR A 176 -1 N GLN A 175 O ARG A 181 SHEET 3 AA1 6 SER A 133 ASP A 140 1 N PHE A 137 O MET A 174 SHEET 4 AA1 6 PHE A 234 THR A 241 1 O VAL A 238 N ALA A 136 SHEET 5 AA1 6 ILE A 265 GLY A 270 1 O ILE A 265 N LEU A 237 SHEET 6 AA1 6 VAL A 296 GLN A 298 1 O PHE A 297 N VAL A 268 LINK OG SER A 142 MG MG A 401 1555 1555 2.12 LINK OG SER A 144 MG MG A 401 1555 1555 2.18 LINK OG1 THR A 209 MG MG A 401 1555 1555 2.12 LINK MG MG A 401 O1A SIM A 402 1555 1555 2.06 LINK MG MG A 401 O HOH A 563 1555 1555 2.11 LINK MG MG A 401 O HOH A 564 1555 1555 2.05 CISPEP 1 LYS A 290 PRO A 291 0 -6.10 SITE 1 AC1 6 SER A 142 SER A 144 THR A 209 SIM A 402 SITE 2 AC1 6 HOH A 563 HOH A 564 SITE 1 AC2 15 SER A 142 GLY A 143 SER A 144 ARG A 151 SITE 2 AC2 15 LYS A 154 SER A 158 ARG A 196 LYS A 200 SITE 3 AC2 15 GLY A 207 ARG A 208 THR A 209 PHE A 246 SITE 4 AC2 15 MG A 401 HOH A 502 HOH A 564 CRYST1 56.380 57.690 58.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017737 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017334 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017123 0.00000